![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
Unintentional substance dependence can develop after taking benzodiazepines for long-term. The aim of this study was to provide treatment for anxiety symptoms with prevention of benzodiazepine dependence through implementation of the Blunk Anxiety Management Protocol (BAMP). The BAMP, for prescribing, tapering, and discontinuation of benzodiazepines, was implemented for new clients who presented with complaints of anxiety symptoms and for clients previously maintained on benzodiazepines. Education was given for those maintained on benzodiazepines for long-term. Rates of continued long-term benzodiazepine maintenance, dose reduction, and dose discontinuation were measured. For new clients entering care, 29% consented for participation. There were 172 existing clients maintained long-term on benzodiazepines. Of these, 37% or 63 clients consented to participate and received education of benzodiazepines and the process of tapering toward discontinuing. In addition, clients who elected to remain on a benzodiazepine dose, with an outside provider, were 30%. Those who were in the process of a dose reduction from the originally prescribed dose or who were completely off benzodiazepines were 70%. Overall, 70% of the clients who participated were tapered or discontinued from benzodiazepines. When approached with adequate education and active participation by the client, therapeutic discontinuation of benzodiazepines can be effectively accomplished.
Acknowledgments
Acknowledgement goes to the University of South Alabama and to the leadership of personnel consulted for this activity. Special thanks to Promod Bishnoi, the Executive Director, the administrative staff, the personnel at the Belfry Clinic, Walter Owens in the IT Department, and Dr. Wayne Edwards, for his constant reassurance and professional regard during this process.